Title |
Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder
|
---|---|
Published in |
Journal of Autism and Developmental Disorders, April 2018
|
DOI | 10.1007/s10803-018-3571-4 |
Pubmed ID | |
Authors |
Tracy Yuen, Melissa T. Carter, Peter Szatmari, Wendy J. Ungar |
Abstract |
The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 22% |
Spain | 1 | 11% |
Mexico | 1 | 11% |
Unknown | 5 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 78% |
Scientists | 2 | 22% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 98 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 14% |
Unspecified | 13 | 13% |
Student > Master | 13 | 13% |
Student > Bachelor | 11 | 11% |
Student > Ph. D. Student | 7 | 7% |
Other | 11 | 11% |
Unknown | 29 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 20 | 20% |
Unspecified | 13 | 13% |
Medicine and Dentistry | 11 | 11% |
Nursing and Health Professions | 5 | 5% |
Social Sciences | 4 | 4% |
Other | 13 | 13% |
Unknown | 32 | 33% |